Saturday, October 20, 2018

New Paper by SS Tiwari & PN Desai | Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward

Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward
by Shashank S. Tiwari & Pranav N. Desai, Cell Stem Cell, 2018 DOI: 10.1016/j.stem.2018.10.007

Abstract: Hundreds of clinics in India offer unproven stem cell therapies despite having remarkably stringent guidelines and regulations for fraudulent advertisements and clinical practice. We discuss the challenges with current regulations, how a recently proposed amendment may further legitimize unproven stem cell therapies, and discuss paths forward in a global context.

No comments: